Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Delayed Quote USD

Humacyte, Inc. (HUMAW)

Compare
0.3800
+0.0100
+(2.70%)
At close: April 1 at 4:00:00 PM EDT

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings -20.94M

Q1'24

Q2'24

Q3'24

Q4'24

-40M
-20M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5556
Avg. Estimate 457.8k1.17M7.03M81.93M
Low Estimate --460k3.19M35M
High Estimate 1.76M1.84M10M293.28M
Year Ago Sales ------7.03M
Sales Growth (year/est) 0.00%0.00%0.00%1,065.72%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
HUMAW --------
S&P 500 6.69%6.80%9.98%14.34%

Related Tickers